skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 49  for All Library Resources

Results 1 2 3 next page
Refined by: subject: Clinical Trials remove Journal Title: Cancers remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Molecular Characterization and Treatment Approaches for Pediatric IH3 K27/I-Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant Data
Material Type:
Article
Add to My Research

Molecular Characterization and Treatment Approaches for Pediatric IH3 K27/I-Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant Data

Cancers, 2023-07, Vol.15 (13) [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15133478

Full text available

2
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Material Type:
Article
Add to My Research

Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges

Cancers, 2024-02, Vol.16 (4), p.794 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16040794 ;PMID: 38398185

Full text available

3
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
Material Type:
Article
Add to My Research

A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines

Cancers, 2024-01, Vol.16 (2), p.335 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16020335 ;PMID: 38254823

Full text available

4
Interpreting Randomized Controlled Trials
Material Type:
Article
Add to My Research

Interpreting Randomized Controlled Trials

Cancers, 2023-09, Vol.15 (19), p.4674 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15194674 ;PMID: 37835368

Full text available

5
Quality of Life and Independent Factors Associated with Poor Digestive Function after Ivor Lewis Esophagectomy
Material Type:
Article
Add to My Research

Quality of Life and Independent Factors Associated with Poor Digestive Function after Ivor Lewis Esophagectomy

Cancers, 2023-11, Vol.15 (23), p.5569 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15235569 ;PMID: 38067274

Full text available

6
A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China
Material Type:
Article
Add to My Research

A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China

Cancers, 2023-08, Vol.15 (16), p.4060 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15164060 ;PMID: 37627088

Full text available

7
Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers
Material Type:
Article
Add to My Research

Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers

Cancers, 2023-08, Vol.15 (16), p.4099 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15164099 ;PMID: 37627127

Full text available

8
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas
Material Type:
Article
Add to My Research

Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas

Cancers, 2023-10, Vol.15 (20), p.5036 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15205036 ;PMID: 37894403

Full text available

9
Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?
Material Type:
Article
Add to My Research

Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?

Cancers, 2023-08, Vol.15 (17), p.4262 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15174262 ;PMID: 37686537

Full text available

10
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences
Material Type:
Article
Add to My Research

Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences

Cancers, 2023-05, Vol.15 (11), p.2948 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15112948 ;PMID: 37296910

Full text available

11
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
Material Type:
Article
Add to My Research

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)

Cancers, 2023-08, Vol.15 (16), p.4028 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15164028 ;PMID: 37627056

Full text available

12
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review
Material Type:
Article
Add to My Research

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers, 2023-04, Vol.15 (9), p.2561 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15092561 ;PMID: 37174027

Full text available

13
Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells
Material Type:
Article
Add to My Research

Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells

Cancers, 2023-07, Vol.15 (14), p.3627 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15143627 ;PMID: 37509288

Full text available

14
Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
Material Type:
Article
Add to My Research

Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives

Cancers, 2023-03, Vol.15 (7), p.2074 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15072074 ;PMID: 37046734

Full text available

15
Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial
Material Type:
Article
Add to My Research

Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial

Cancers, 2023-05, Vol.15 (10), p.2809 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15102809 ;PMID: 37345146

Full text available

16
Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial
Material Type:
Article
Add to My Research

Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial

Cancers, 2023-04, Vol.15 (9), p.2543 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15092543 ;PMID: 37174008

Full text available

17
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)
Material Type:
Article
Add to My Research

Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)

Cancers, 2023-04, Vol.15 (9), p.2441 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. 2023 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers15092441 ;PMID: 37173908

Full text available

18
Six-Month Prostate Cancer Empowerment Program (PC-PEP) Improves Urinary Function: A Randomized Trial
Material Type:
Article
Add to My Research

Six-Month Prostate Cancer Empowerment Program (PC-PEP) Improves Urinary Function: A Randomized Trial

Cancers, 2024-02, Vol.16 (5), p.958 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. 2024 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16050958 ;PMID: 38473319

Full text available

19
Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic
Material Type:
Article
Add to My Research

Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic

Cancers, 2024-04, Vol.16 (7), p.1396 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16071396 ;PMID: 38611074

Full text available

20
Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis Model
Material Type:
Article
Add to My Research

Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis Model

Cancers, 2024-04, Vol.16 (7), p.1360 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16071360 ;PMID: 38611037

Full text available

Results 1 - 20 of 49  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait